Form 4: Hims & Hers Director Deborah M. Autor Acquires Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Deborah M. Autor of Hims & Hers Health, Inc. was granted restricted stock units (RSUs) on November 15, 2024, which will vest over the next three years and at the 2025 annual meeting.

Summary

  • Deborah M. Autor, a director at Hims & Hers Health, Inc., received two grants of restricted stock units (RSUs) on November 15, 2024.
  • The first grant consists of 21,164 RSUs, which will vest in three equal installments on December 15, 2025, December 15, 2026, and December 15, 2027.
  • The second grant consists of 6,175 RSUs, which will vest on the earlier of the date of the 2025 annual meeting of stockholders or June 15, 2025.
  • Each RSU represents a contingent right to receive one share of Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of equity compensation for a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

  • The grant of RSUs to a director aligns their interests with the long-term performance of the company.
  • The vesting schedule of the RSUs encourages continued service and commitment from the director.

Future Outlook

The vesting of the RSUs is contingent on continued service by the director, aligning her interests with the company's long-term success.

Industry Context

The granting of stock-based compensation to directors is a common practice in the technology and healthcare industries to incentivize performance and align interests with shareholders.

Comparison to Industry Standards

  • Stock-based compensation is a standard practice for directors in publicly traded companies, particularly in the tech and healthcare sectors.
  • The vesting schedule of the RSUs is typical, with a mix of time-based and event-based vesting conditions.
  • Companies like Teladoc Health and GoodRx also use similar equity compensation structures for their board members.

Stakeholder Impact

  • Shareholders may view the RSU grant positively as it aligns the director's interests with the company's performance.
  • The director is incentivized to contribute to the company's success to realize the value of the RSUs.

Next Steps

  • The director will continue to provide service to the company to fulfill the vesting requirements of the RSUs.
  • The company will monitor the vesting schedule and issue shares of Class A Common Stock upon vesting.

Key Dates

DateDescription
11/15/2024Date of the RSU grants to Deborah M. Autor.
12/15/2025First vesting date for 1/3 of the 21,164 RSUs.
06/15/2025Potential vesting date for the 6,175 RSUs if the annual meeting is not before this date.
12/15/2026Second vesting date for 1/3 of the 21,164 RSUs.
12/15/2027Final vesting date for 1/3 of the 21,164 RSUs.

Keywords

Restricted Stock Units, RSU, Director, Hims & Hers Health, Equity Compensation, Vesting, Class A Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.